newsfilter
← Latest News
Business Wire·

Miravo Healthcare™ Announces Third Quarter 2021 Results

- Q3 2021 Adjusted Total Revenue - $17.1 million - - Q3 2021 Adjusted EBITDA - $7.0 million - - Blexten Canadian Prescriptions Increased 16% Year-Over-Year - - Cambia Canadian Prescriptions Increased 5% Year-Over-Year - Miravo to Host Confer